Researchers from around the world will meet November 8th to 11th, 2012 in Seville, Spain. Here they will reveal more news about the great potentials from the substance Q10 in the prevention and treatment of Q10 deficiency, which is an area where Pharma Nord has been one of the pioneers.
Since 1990, Pharma Nord has been conducted and published more than 100 studies on the product Bio-Qiunon Q10. Also on this the 7th Congress of the International Coenzyme Q10 Association, there will be presented a study conducted with a Pharma Nord Q10 product. A study that has been ongoing for 4 years in 18 hospital centers all over the world.